Home › Migraine › Illinois › Chicago
Migraine clinical trials in Chicago, IL
4 studies for Migraine are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
RecruitingPhase 3
- Chicago Headache Center & Research Institute, Chicago
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
RecruitingPhase 3
- Chicago Headache Center & Research Institute, Chicago
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
RecruitingPhase 3
- Chicago Headache Center & Research Institute /ID# 248625, Chicago
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
RecruitingPhase 3
- Cedar Crosse Research Center, Chicago
- Chicago Headache Center & Research Institute, Chicago
About Migraine
Migraines are pulsing or throbbing headaches in one area of the head. Learn about other symptoms, what triggers migraines, and how to treat them.
More about Migraine on MedlinePlus
Migraine trials in other cities
- Cincinnati, OH11 studies
- Miami, FL8 studies
- Austin, TX8 studies
- Philadelphia, PA8 studies
- Concord, CA8 studies
- Amherst, NY7 studies
- Omaha, NE7 studies
- Houston, TX7 studies
- Washington, DC7 studies
- Aurora, CO6 studies
- Stamford, CT6 studies
- San Diego, CA6 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer58 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Obesity41 studies
- Lung Cancer41 studies
- Ovarian Cancer36 studies
- Stroke34 studies
- Colorectal Cancer33 studies
- Heart Failure31 studies
- Overweight28 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.